BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1732994)

  • 1. 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and in humans.
    Melnick RL; Huff J
    Rev Environ Contam Toxicol; 1992; 124():111-44. PubMed ID: 1732994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
    Bond JA; Medinsky MA
    Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3-butadiene: cancer, mutations, and adducts. Part I: Carcinogenicity of 1,2,3,4-diepoxybutane.
    Henderson RF; Barr EB; Belinsky SA; Benson JM; Hahn FF; Ménache MG
    Res Rep Health Eff Inst; 2000 Mar; (92):11-43; discussion 45-8. PubMed ID: 10925838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
    Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
    Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalation toxicology and carcinogenicity of 1,3-butadiene in B6C3F1 mice following 65 weeks of exposure.
    Melnick RL; Huff JE; Roycroft JH; Chou BJ; Miller RA
    Environ Health Perspect; 1990 Jun; 86():27-36. PubMed ID: 2401263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
    Motwani HV; Törnqvist M
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative carcinogenicity of 1,3-butadiene, isoprene, and chloroprene in rats and mice.
    Melnick RL; Sills RC
    Chem Biol Interact; 2001 Jun; 135-136():27-42. PubMed ID: 11397379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenicity of 1,3-butadiene.
    Melnick RL; Shackelford CC; Huff J
    Environ Health Perspect; 1993 Apr; 100():227-36. PubMed ID: 8354171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the genetic and related effects of 1,3-butadiene in rodents and humans.
    Jackson MA; Stack HF; Rice JM; Waters MD
    Mutat Res; 2000 Oct; 463(3):181-213. PubMed ID: 11018742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
    Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
    Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 434():1-389. PubMed ID: 12616297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research strategy for assessing target tissue dosimetry of 1,3-butadiene in laboratory animals and humans.
    Bond JA; Csanády GA; Leavens T; Medinsky MA
    IARC Sci Publ; 1993; (127):45-55. PubMed ID: 8070886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene.
    Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
    Carcinogenesis; 1995 Aug; 16(8):1723-31. PubMed ID: 7634396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,3-Butadiene induces cancer in experimental animals at all concentrations from 6.25 to 8000 parts per million.
    Melnick RL; Huff JE
    IARC Sci Publ; 1993; (127):309-22. PubMed ID: 8070878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F1 mice following a single and repeated exposures to 1,3-butadiene via inhalation.
    Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
    Toxicology; 1997 Nov; 123(1-2):125-34. PubMed ID: 9347927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
    Csanády GA; Guengerich FP; Bond JA
    Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace.
    Bond JA; Recio L; Andjelkovich D
    Carcinogenesis; 1995 Feb; 16(2):165-71. PubMed ID: 7859344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.